236 related articles for article (PubMed ID: 27783276)
1. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Sasatomi Y; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
Clin Exp Nephrol; 2017 Dec; 21(6):961-970. PubMed ID: 27783276
[TBL] [Abstract][Full Text] [Related]
2. Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Shuto H; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
Clin Exp Nephrol; 2014 Oct; 18(5):784-94. PubMed ID: 24363128
[TBL] [Abstract][Full Text] [Related]
3. [Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].
Goto M; Ikeda M; Hataya H; Ishikura K; Hamasaki Y; Honda M
Nihon Jinzo Gakkai Shi; 2006; 48(4):365-70. PubMed ID: 16780106
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
Matsumoto Y; Shimada Y; Nojima Y; Moriki T
Ren Fail; 2013 Aug; 35(7):936-41. PubMed ID: 23815417
[TBL] [Abstract][Full Text] [Related]
5. Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine.
Ito T; Mochizuki K; Oka T; Hanada K; Tanabe K
Int Urol Nephrol; 2015 Jan; 47(1):131-5. PubMed ID: 25298141
[TBL] [Abstract][Full Text] [Related]
6. A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
Tsubouchi Y; Fukuda W; Kawahito Y; Kohno M; Wada M; Ishino H; Hamaguchi M; Yamamoto A; Kadoya M; Niimi M; Yoshikawa T
Mod Rheumatol; 2008; 18(1):91-5. PubMed ID: 18159569
[TBL] [Abstract][Full Text] [Related]
7. Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy.
Nishioka Y; Horita Y; Tadokoro M; Taura K; Suyama N; Miyazaki M; Harada T; Kohno S
Nephrol Dial Transplant; 2006 Aug; 21(8):2337-8. PubMed ID: 16547120
[No Abstract] [Full Text] [Related]
8. High-dose mizoribine treatment for adolescents with systemic lupus erythematosus.
Nozu K; Iijima K; Kamioka I; Fujita T; Yoshiya K; Tanaka R; Nakanishi K; Yoshikawa N; Matsuo M
Pediatr Int; 2006 Apr; 48(2):152-7. PubMed ID: 16635174
[TBL] [Abstract][Full Text] [Related]
9. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome.
Tanaka H; Tsugawa K; Nakahata T; Kudo M; Onuma S; Kimura S; Ito E
Tohoku J Exp Med; 2005 Jan; 205(1):87-91. PubMed ID: 15635277
[TBL] [Abstract][Full Text] [Related]
10. Assessment of factors associated with mizoribine responsiveness in children with steroid-dependent nephrotic syndrome.
Kondoh T; Ikezumi Y; Yokoi K; Nakajima Y; Matsumoto Y; Kaneko M; Hasegawa H; Yamada T; Kumagai N; Ito T; Yoshikawa T
Clin Exp Nephrol; 2019 Sep; 23(9):1154-1160. PubMed ID: 31187341
[TBL] [Abstract][Full Text] [Related]
11. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of mizoribine administration in children with frequently relapsing nephrotic syndrome, and the relationship between pharmacokinetic parameters and efficacy: a multicenter prospective cohort study in China.
Xia ZK; Gao YF; Rong LP; Dang XQ; Shen Q; Jiang XY; Yi ZW; Xu H
World J Pediatr; 2019 Jun; 15(3):262-269. PubMed ID: 30864060
[TBL] [Abstract][Full Text] [Related]
13. Mizoribine for the treatment of lupus nephritis in children and adolescents.
Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
[TBL] [Abstract][Full Text] [Related]
14. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
Kawasaki Y; Hosoya M; Kobayashi S; Ohara S; Onishi N; Takahashi A; Isome M; Suzuki H
Nephrol Dial Transplant; 2005 Oct; 20(10):2243-7. PubMed ID: 16030039
[TBL] [Abstract][Full Text] [Related]
15. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
Fujieda M; Ishihara M; Morita T; Hayashi A; Okada S; Ohta T; Sakano T; Wakiguchi H
Clin Nephrol; 2012 Jul; 78(1):40-6. PubMed ID: 22732336
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q; Li H; Xie X; Qu F; Li X; Chen J
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[TBL] [Abstract][Full Text] [Related]
17. Effect of mizoribine pulse therapy in adult membranous nephropathy.
Wang X; Zhang M; Zhang W; Liu Y; Han Y; Chang W
Int Urol Nephrol; 2021 Apr; 53(4):725-731. PubMed ID: 33159256
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of mizoribine in child-onset glomerulonephritis.
Abe Y; Mikawa T; Fuke T; Hisano M; Tsuji Y; Watanabe S; Itabashi K
Pediatr Int; 2008 Oct; 50(5):615-9. PubMed ID: 19261105
[TBL] [Abstract][Full Text] [Related]
19. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Sako M; Saito-Oba M; Nozu K; Shima Y; Iijima K; Yoshikawa N;
BMC Nephrol; 2018 Sep; 19(1):223. PubMed ID: 30200895
[TBL] [Abstract][Full Text] [Related]
20. A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).
Shibasaki T; Koyama A; Hishida A; Muso E; Osawa G; Yamabe H; Shiiki H; Makino H; Sato H; Ishikawa I; Maeda K; Tomita K; Arakawa M; Ishida M; Sato M; Nagase M; Kashihara N; Yorioka N; Koike T; Saito T; Harada T; Mitarai T; Sugisaki T; Nagasawa T; Tomino Y; Nojima Y; Kobayashi Y; Sakai O
Clin Exp Nephrol; 2004 Jun; 8(2):117-26. PubMed ID: 15235928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
